1. Berger, W., Göschke, H., Heding, L.G., Künzli, H.: Insulin secretion after oral tolbutamide or Ro 6-4563 in man. Studies in portal venous blood by transumbilical vein catheterization. In: Dubach, K.C., A. Bückert: Recent hypoglycemic sulfonylureas. p. 246?253, Huber, Bern 1971
2. Blumenbach, L., Gerhards, E., Gutsche, H., Klein, W., Loge, O., Losert, W., Schillinger, E., Speck, U., Vetter, H., Wendt, H.: Gliflumide, a new oral antidiabetic of high potency and efficacy. Int. J. Clin. Pharmacol.12, 141?151 (1975)
3. Brown, J.C., Dryburgh, J.R.: A gastric inhibitory polypeptide. II. The complete amino acid sequence. Can. J. Biochem.49, 867?872 (1971)
4. Dupré, J., Ross, S.A., Watson, D., Brown, J.C.: Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J. Clin. Endoer.24, 826?833 (1973)
5. Frerichs, H., Puls, W.: Vergleichende Untersuchungen zu hypoglykämischen, Seruminsulin-steigernden und UFS-beeinflussenden Wirkung von beta-cytotropen Antidiabetica an gesunden Versuchspersonen. Verh. dtsch. Ges. inn. Med.76, 441?445 (1970)